Zimmer Biomet Holdings, Inc. · NYSE:ZBH
Zimmer Biomet — Merger or Acquisition (January 2025)
8 slides from Zimmer Biomet's merger presentation, Jan 29, 2025
Slide 1: Acquisition of Paragon 28
Exhibit 99.2 ZIMMER BIOMET MOVING YOU MOVING YOU F FO OR RW WA AR RD D ZBH Acquisition of Paragon 28 2024 Investor Day January 28, 2025
Slide 2: Disclaimer: Cautionary Note Regarding Forward-Looking Statements
Disclaimer Cautionary Note Regarding Forward-Looking Statements: This presentation contains forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, including any statements about us; Paragon 28, Inc. (“Paragon 28”); forecas
Slide 3: Summary of definitive agreement to acquire Paragon 28
Zimmer Biomet has entered into a definitive agreement to acquire all of the outstanding shares of Paragon 28, Inc. (NYSE:FNA), a leading medical device company focused exclusively on the foot and ankle orthopedic segment. The 1 transaction values Paragon 28 at approximately $1.2 billion Paragon 28’s
Slide 4: Strategic Rationale
Strategic Rationale Expands Accelerates Complements Expedites Strengthens F&A deformity Zimmer Biomet’s Zimmer Biomet’s Zimmer Biomet’s Zimmer Biomet’s 1 offerings through WAMGR given global footprint expansion leadership position Paragon 28’s leading significant opportunity and existing opportuniti
Slide 5: Transaction Details
Transaction Details 1 $13 per share in cash corresponding to an approximate $1.2B enterprise value Purchase Price and Contingent Value One non-tradable CVR which may pay up to an additional $1 per share in cash based on achievement of Right (CVR) Structure revenue milestones Zimmer Biomet plans to f
Slide 6: F&A Segment Opportunity
F&A Segment Opportunity 1 2 Global Foot & Ankle Segment Foot & Ankle Segment Allocation 2024 - 2028 CAGR (%) Large Forefoot 10 CAGR $6.9B ~13,700 Fracture Fixation 5 ~7% $5.2B U.S. Foot & Flatfoot / PCFD 3 Ankle Ankle 9 Charcot 4 Surgeon Base 2024 2028 Biologics 6 3 orthopedic surgeons that Fast Gro
Slide 7: Paragon Overview
Paragon 28 Overview 1 Product Portfolio Annual Revenue Fracture & Trauma Deformity Correction Joint Replacement Bun-Yo-Matic Lapidus Gorilla® R3con Plating System APEX 3D Total $256 Clamp Ankle Replacement 19% CAGR System $216 $181 Monkey Rings External Fixation System $147 Phantom® Hindfoot TTC/TC
Slide 8: A Reminder on Our M&A Strategy Criteria
A Reminder on Our M&A Strategy Criteria Paragon 28 Transaction Value Less than $2bn✓ Immediately Accretive to Revenue Growth✓ Adj. EPS Neutral by the End of Year 2✓ High-Single Digit ROIC by Year 5✓ Path to Category Leadership✓ Differentiated Protected Solutions✓ Improve Safety, Efficiency, Best-in-
Zimmer Biomet Holdings — Merger or Acquisition (January 2025) on 6ix